These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1442209)

  • 1. The bisphosphonate, alendronate, prevents bone loss in ovariectomized baboons.
    Thompson DD; Seedor JG; Quartuccio H; Solomon H; Fioravanti C; Davidson J; Klein H; Jackson R; Clair J; Frankenfield D
    J Bone Miner Res; 1992 Aug; 7(8):951-60. PubMed ID: 1442209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.
    Balena R; Toolan BC; Shea M; Markatos A; Myers ER; Lee SC; Opas EE; Seedor JG; Klein H; Frankenfield D
    J Clin Invest; 1993 Dec; 92(6):2577-86. PubMed ID: 8254015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat.
    Gasser JA; Ingold P; Venturiere A; Shen V; Green JR
    J Bone Miner Res; 2008 Apr; 23(4):544-51. PubMed ID: 18072878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
    Hornby SB; Evans GP; Hornby SL; Pataki A; Glatt M; Green JR
    Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
    Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minodronic acid (ONO-5920/YM529) prevents decrease in bone mineral density and bone strength, and improves bone microarchitecture in ovariectomized cynomolgus monkeys.
    Mori H; Tanaka M; Kayasuga R; Masuda T; Ochi Y; Yamada H; Kishikawa K; Ito M; Nakamura T
    Bone; 2008 Nov; 43(5):840-8. PubMed ID: 18718565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the bisphosphonate YM175 on bone mineral density, strength, structure, and turnover in ovariectomized beagles on concomitant dietary calcium restriction.
    Motoie H; Nakamura T; O'uchi N; Nishikawa H; Kanoh H; Abe T; Kawashima H
    J Bone Miner Res; 1995 Jun; 10(6):910-20. PubMed ID: 7572315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats.
    Seedor JG; Quartuccio HA; Thompson DD
    J Bone Miner Res; 1991 Apr; 6(4):339-46. PubMed ID: 1858520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of concurrent administration of alendronate sodium and retinol on development of changes in histomorphometric parameters of bones induced by ovariectomy in rats.
    Pytlik M; Kaczmarczyk-Sedlak I; Sliwiński L; Janiec W; Rymkiewicz I
    Pol J Pharmacol; 2004; 56(5):571-9. PubMed ID: 15591645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis.
    Rossini M; Gatti D; Zamberlan N; Braga V; Dorizzi R; Adami S
    J Bone Miner Res; 1994 Nov; 9(11):1833-7. PubMed ID: 7863833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
    Confavreux CB; Fontana A; Guastalla JP; Munoz F; Brun J; Delmas PD
    Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zoledronate prevents the development of absolute osteopenia following ovariectomy in adult rhesus monkeys.
    Binkley N; Kimmel D; Bruner J; Haffa A; Davidowitz B; Meng C; Schaffer V; Green J
    J Bone Miner Res; 1998 Nov; 13(11):1775-82. PubMed ID: 9797488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the bisphosphonate zoledronate on bone loss in the ovariectomized and in the adjuvant arthritic rat.
    Müller K; Wiesenberg I; Jaeggi K; Green JR
    Arzneimittelforschung; 1998 Jan; 48(1):81-6. PubMed ID: 9522039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a bisphosphonate and selective estrogen receptor modulator on bone remodeling in streptozotocin-induced diabetes and ovariectomized rat model.
    Lee YS; Gupta R; Kwon JT; Cho DC; Seo YJ; Seu SY; Park EK; Han I; Kim CH; Sung JK; Kim KT
    Spine J; 2018 Oct; 18(10):1877-1887. PubMed ID: 29793000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulatory effects of Aroclors 1221 and 1254 on bone turnover and vertebral histology in intact and ovariectomized rats.
    Yilmaz B; Seyran AD; Sandal S; Aydin M; Colakoglu N; Kocer M; Carpenter DO
    Toxicol Lett; 2006 Oct; 166(3):276-84. PubMed ID: 16978806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of continuous alendronate treatment on bone mass and mechanical properties in ovariectomized rats: comparison with pamidronate and etidronate in growing rats.
    Azuma Y; Oue Y; Kanatani H; Ohta T; Kiyoki M; Komoriya K
    J Pharmacol Exp Ther; 1998 Jul; 286(1):128-35. PubMed ID: 9655851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone functional changes in intact, ovariectomized, and ovariectomized, hormone-supplemented adult cynomolgus monkeys (Macaca fascicularis) evaluated by serum markers and dynamic histomorphometry.
    Jerome CP; Carlson CS; Register TC; Bain FT; Jayo MJ; Weaver DS; Adams MR
    J Bone Miner Res; 1994 Apr; 9(4):527-40. PubMed ID: 8030441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Droloxifene prevents ovariectomy-induced bone loss in tibiae and femora of aged female rats: a dual-energy X-ray absorptiometric and histomorphometric study.
    Chen HK; Ke HZ; Jee WS; Ma YF; Pirie CM; Simmons HA; Thompson DD
    J Bone Miner Res; 1995 Aug; 10(8):1256-62. PubMed ID: 8585430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of modal damping factor as a diagnostic tool for osteoporosis and its relation with serum osteocalcin and collagen I N-telopeptide for monitoring the efficacy of alendronate in ovariectomized rats.
    Christopoulou GE; Stavropoulou A; Anastassopoulos G; Panteliou SD; Papadaki E; Karamanos NK; Panagiotopoulos E
    J Pharm Biomed Anal; 2006 Jun; 41(3):891-7. PubMed ID: 16488571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.